Clinical Trial Update: Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating etanercept for skin and joint disease in psoriatic arthritis completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriatic Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2009-05-27